MCID: PLX002
MIFTS: 39

Plexiform Neurofibroma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Plexiform Neurofibroma

MalaCards integrated aliases for Plexiform Neurofibroma:

Name: Plexiform Neurofibroma 12 6 15 17 74
Neurofibroma, Plexiform 45
Neurofibroma Plexiform 56

Classifications:



External Ids:

Disease Ontology 12 DOID:5151
MeSH 45 D018318
NCIt 51 C3797
SNOMED-CT 69 41252002
UMLS 74 C0206728

Summaries for Plexiform Neurofibroma

MalaCards based summary : Plexiform Neurofibroma, also known as neurofibroma, plexiform, is related to neurofibromatosis, type i and neurofibromatosis, type iv, of riccardi. An important gene associated with Plexiform Neurofibroma is CDKN2B-AS1 (CDKN2B Antisense RNA 1), and among its related pathways/superpathways is Cell cycle_Role of APC in cell cycle regulation. The drugs Peginterferon alfa-2b and Celecoxib have been mentioned in the context of this disorder. Affiliated tissues include tongue, bone and spinal cord, and related phenotype is respiratory system.

Related Diseases for Plexiform Neurofibroma

Diseases related to Plexiform Neurofibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 85)
# Related Disease Score Top Affiliating Genes
1 neurofibromatosis, type i 32.7 CDKN2B-AS1 NF1
2 neurofibromatosis, type iv, of riccardi 32.3 CDKN2B-AS1 NF1 NF2
3 neurofibroma 32.3 NF1 NF2
4 neurofibrosarcoma 30.8 NF1 NF2
5 malignant peripheral nerve sheath tumor 30.5 NF1 NF2
6 neurilemmoma 30.3 NF1 NF2
7 cellular schwannoma 30.2 NF1 NF2
8 neuroma 30.1 ANK3 NF2
9 chromosome 17q11.2 deletion syndrome 11.4
10 painful orbital and systemic neurofibromas-marfanoid habitus syndrome 11.4
11 neurofibromatosis, familial spinal 10.2 NF1 NF2
12 plexiform schwannoma 10.2 NF1 NF2
13 immature cataract 10.2 NF1 NF2
14 atypical neurofibroma 10.2 NF1 NF2
15 trigeminal nerve neoplasm 10.2 NF1 NF2
16 neurilemmoma of the fifth cranial nerve 10.2 NF1 NF2
17 amyloid tumor 10.2 NF1 NF2
18 spinal meningioma 10.2 NF1 NF2
19 carpal tunnel syndrome 10.2
20 pulmonary alveolar microlithiasis 10.2
21 mononeuropathy of the median nerve, mild 10.2
22 human venous malformation 10.2
23 scoliosis 10.2
24 impotence 10.2
25 gangliocytoma 10.2
26 ganglioneuroma 10.2
27 spinal canal and spinal cord meningioma 10.2 NF1 NF2
28 optic nerve neoplasm 10.1 NF1 NF2
29 acoustic neuroma 10.1 NF1 NF2
30 neurofibromatosis, type ii 10.1 NF1 NF2
31 legius syndrome 10.1 NF1 SPRED1
32 peripheral nervous system neoplasm 10.1 NF1 NF2
33 central nervous system cancer 10.0 NF1 NF2
34 hemifacial hyperplasia 10.0
35 hair whorl 10.0
36 lipomatosis, multiple 10.0
37 macrodactyly 10.0
38 otitis media 10.0
39 pectus excavatum 10.0
40 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.0
41 hemangiopericytoma, malignant 10.0
42 myasthenia gravis 10.0
43 becker nevus syndrome 10.0
44 gastrointestinal stromal tumor 10.0
45 sacrococcygeal teratoma 10.0
46 angiosarcoma 10.0
47 oculocutaneous albinism 10.0
48 ptosis 10.0
49 congenital ptosis 10.0
50 pleomorphic lipoma 10.0

Graphical network of the top 20 diseases related to Plexiform Neurofibroma:



Diseases related to Plexiform Neurofibroma

Symptoms & Phenotypes for Plexiform Neurofibroma

MGI Mouse Phenotypes related to Plexiform Neurofibroma:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 respiratory system MP:0005388 9.02 ANK3 BUB1B NF1 NF2 SPRED1

Drugs & Therapeutics for Plexiform Neurofibroma

Drugs for Plexiform Neurofibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 75)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Peginterferon alfa-2b Approved Phase 2,Phase 1 215647-85-1, 99210-65-8
2
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
3
Vincristine Approved, Investigational Phase 2 2068-78-2, 57-22-7 5978
4
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
5
Everolimus Approved Phase 2 159351-69-6 70789204 6442177
6
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
7
Sirolimus Approved, Investigational Phase 2 53123-88-9 46835353 5284616 6436030
8
leucovorin Approved Phase 2 58-05-9 143 6006
9
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
10
Vinblastine Approved Phase 2 865-21-4 241903 13342
11
Pirfenidone Approved, Investigational Phase 2,Phase 1 53179-13-8 40632
12
Ifosfamide Approved Phase 2 3778-73-2 3690
13
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
14
Etoposide Approved Phase 2 33419-42-0 36462
15
Lenograstim Approved, Investigational Phase 2 135968-09-1
16
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
17
Trametinib Approved Phase 1, Phase 2,Phase 2 871700-17-3 11707110
18
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
20
Tyrosine Approved, Investigational, Nutraceutical Phase 2,Phase 1 60-18-4 6057
21
Serine Approved, Nutraceutical Phase 2 56-45-1 5951
22
tipifarnib Investigational Phase 2 192185-72-1 159324
23
Doxil Approved June 1999 Phase 2 31703
24
Maleic acid Experimental, Investigational Phase 2 110-17-8, 110-16-7 444972
25
Cediranib Investigational Phase 2 288383-20-0 9933475
26 Antirheumatic Agents Phase 2,Phase 1
27 Peripheral Nervous System Agents Phase 2,Phase 1
28 Antineoplastic Agents, Alkylating Phase 2
29 Antineoplastic Agents, Phytogenic Phase 2
30 Immunologic Factors Phase 2,Phase 1
31 Interferon-alpha Phase 2,Phase 1
32 Antiviral Agents Phase 2,Phase 1
33 Anti-Infective Agents Phase 2,Phase 1
34 Interferon alpha-2 Phase 2,Phase 1
35 Analgesics Phase 2,Phase 1
36 Anti-Inflammatory Agents, Non-Steroidal Phase 2,Phase 1
37 Alkylating Agents Phase 2
38 Antimitotic Agents Phase 2
39 Anti-Inflammatory Agents Phase 2,Phase 1
40 Cyclooxygenase 2 Inhibitors Phase 2
41 Analgesics, Non-Narcotic Phase 2,Phase 1
42 interferons Phase 2,Phase 1
43 Cyclooxygenase Inhibitors Phase 2
44 Immunosuppressive Agents Phase 2
45 Anti-Bacterial Agents Phase 2
46 Antibiotics, Antitubercular Phase 2
47 Antifungal Agents Phase 2
48 Pharmaceutical Solutions Phase 2,Phase 1
49 Nucleic Acid Synthesis Inhibitors Phase 2
50 Folic Acid Antagonists Phase 2

Interventional clinical trials:

(show all 50)
# Name Status NCT ID Phase Drugs
1 Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain Recruiting NCT02471339 Phase 3
2 Medical Treatment of "High-Risk" Neurofibromas Unknown status NCT00846430 Phase 2 Peg-Interferon alpha-2b;Celecoxib (Celebrex);Temozolomide (temodar);Vincristine Sulfate (Oncovin)
3 Study of PEG-Intron for Plexiform Neurofibromas Completed NCT00396019 Phase 2 PEG-Intron
4 Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas Completed NCT01412892 Phase 2 RAD001: Everolimus
5 A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas Completed NCT00634270 Phase 2 Sirolimus
6 Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas Completed NCT00030264 Phase 2 Methotrexate;Vinblastine
7 Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas Completed NCT00076102 Phase 2 Pirfenidone
8 Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Completed NCT01673009 Phase 2 Gleevec
9 Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Completed NCT01140360 Phase 1, Phase 2 Gleevec
10 R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas Completed NCT00021541 Phase 2 tipifarnib
11 MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 Completed NCT02096471 Phase 2 PD-0325901
12 Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 Completed NCT00754780 Phase 2 Pirfenidone
13 Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors Completed NCT00304083 Phase 2 doxorubicin hydrochloride;etoposide;ifosfamide
14 Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Recruiting NCT02101736 Phase 2 Cabozantinib
15 Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas Recruiting NCT03231306 Phase 2 Binimetinib
16 MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas Recruiting NCT02407405 Phase 2 Selumetinib
17 Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway. Recruiting NCT03363217 Phase 1, Phase 2 Trametinib
18 Treatment of NF1-related Plexiform Neurofibroma With Trametinib Recruiting NCT03741101 Phase 2 Trametinib
19 PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Recruiting NCT02390752 Phase 1, Phase 2 PLX3397
20 Study of Imatinib in Children With Neurofibromatosis and Airway Tumors Recruiting NCT03688568 Phase 2 Imatinib Mesylate
21 AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors Active, not recruiting NCT01362803 Phase 1, Phase 2 AZD6244
22 MEK Inhibitor PD-0325901 in Patients With Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas Not yet recruiting NCT03962543 Phase 2 PD-0325901 oral capsule
23 Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours Not yet recruiting NCT03326388 Phase 1, Phase 2 Selumetinib
24 SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors Not yet recruiting NCT03433183 Phase 2 Selumetinib;Sirolimus
25 Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1) Terminated NCT01365468 Phase 2 Everolimus (RAD001)
26 Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas Terminated NCT02177825 Phase 2 Imatinib Mesylate
27 Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas Terminated NCT01402817 Phase 2 Sutent®/Sunitinib
28 AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine Terminated NCT00326872 Phase 2 Cediranib Maleate
29 Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) Withdrawn NCT03109301 Phase 2 Selumetinib (AZD6244 hyd sulfate) 50mg/dose;Selumetinib (AZD6244 hyd sulfate) 25mg/m2
30 Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas Completed NCT00727233 Phase 1 Nexavar (BAY 43-9006) (Sorafenib);Toxicity, Pharmacokinetics;Pharmacodynamics;Radiographic Evaluation;QOL assessment, Neuropsychological;Bony Toxicity
31 Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas Completed NCT00053937 Phase 1 pirfenidone
32 PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma Completed NCT00253474 Phase 1
33 A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants Completed NCT03649165 Phase 1 Treatment A;Treatment B;Treatment C;Treatment D;Acetaminophen
34 Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Recruiting NCT02211768 Phase 1 [18F]-FLT-PET/CT scans
35 Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations Recruiting NCT02124772 Phase 1 Trametinib;Dabrafenib
36 Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas Terminated NCT00716469 Phase 1 LS11
37 Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach. Unknown status NCT02777775
38 Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis Unknown status NCT01777451
39 Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 Completed NCT00006435
40 Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Completed NCT01275586 Early Phase 1 Tasigna
41 Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development Completed NCT00340522
42 Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) Recruiting NCT02544022
43 Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1 (NF1) on Clinical Treatment Trials Recruiting NCT03531814 Not Applicable
44 Natural History Study of Patients With Neurofibromatosis Type I Recruiting NCT00924196
45 Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Recruiting NCT03141021
46 PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) Active, not recruiting NCT01800032
47 An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1 Available NCT03259633 Selumetinib
48 Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 Enrolling by invitation NCT03820778 Not Applicable
49 Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics Not yet recruiting NCT03027401
50 Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma Terminated NCT00060008 Not Applicable

Search NIH Clinical Center for Plexiform Neurofibroma

Cochrane evidence based reviews: neurofibroma, plexiform

Genetic Tests for Plexiform Neurofibroma

Anatomical Context for Plexiform Neurofibroma

MalaCards organs/tissues related to Plexiform Neurofibroma:

42
Tongue, Bone, Spinal Cord, Salivary Gland, Skin, Eye, Heart

Publications for Plexiform Neurofibroma

Articles related to Plexiform Neurofibroma:

(show top 50) (show all 318)
# Title Authors Year
1
Rare manifestation of Neurofibromatosis type 1: A plexiform neurofibroma involving the mediastinum and lungs with endobronchial neurofibromata. ( 30238622 )
2019
2
Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma. ( 30413310 )
2019
3
Novel Three-Dimensional Morphometry to Reassess Orbit Deformities Associated With Orbital-Periorbital Plexiform Neurofibroma. ( 30664557 )
2019
4
Two cases of debulking surgery for lower limb diffuse plexiform neurofibroma with transcatheter arterial embolisation. ( 30738368 )
2019
5
Simultaneous Forehead Lift and Blepharoplasty Techniques in Management of Orbito-Temporal Plexiform Neurofibroma. ( 30889063 )
2019
6
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1. ( 29718344 )
2018
7
A combination of skeletal deformations of the dorsal mandible and temporomandibular region detected in orthopantomograms of patients with neurofibromatosis type 1 indicates an associated ipsilateral plexiform neurofibroma. ( 29764701 )
2018
8
Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1. ( 29849532 )
2018
9
Large penile plexiform neurofibroma in an 11-year old boy. ( 29868161 )
2018
10
Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. ( 29893754 )
2018
11
Long-Term Results for a One-Stage Surgery Technique for Patients With Craniofacial Plexiform Neurofibroma. ( 29944556 )
2018
12
Unilateral Creeping Destruction of Deformed Mandibular Ramus and Angle Associated with Extensive Facial Plexiform Neurofibroma in Neurofibromatosis Type 1: A Case Report with Analysis of the Literature for Diagnosing Osteolytic Events of the Mandible in Tumor-suppressor Gene Syndrome. ( 29970534 )
2018
13
Mesenteric plexiform neurofibroma. ( 30233045 )
2018
14
Giant plexiform neurofibroma in neurofibromatosis type 1. ( 30246960 )
2018
15
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [18 F]FDG-PET imaging. Is it of value in asymptomatic patients? ( 28771999 )
2018
16
Solitary Plexiform Neurofibroma of the Hepatic Artery. ( 28948502 )
2018
17
Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening. ( 29055717 )
2018
18
Intrahepatic plexiform neurofibroma with neurofibromatosis type 1. ( 29356283 )
2018
19
Plexiform Neurofibroma in the Axilla with Intraosseous Neurofibroma in the Humerus in Neurofibromatosis 5. ( 29441226 )
2018
20
A brief report of plexiform neurofibroma. ( 29449010 )
2018
21
Plexiform Neurofibroma of the Posterior Tibial Nerve Misdiagnosed as Proximal Tarsal Tunnel Syndrome: A Case Report. ( 29497706 )
2018
22
Large Solitary Plexiform Neurofibroma of the Penis Without Erectile Dysfunction: a Case Report from Kerala. ( 29581693 )
2018
23
Unusual Evolution of Plexiform Neurofibroma in the Scalp: A Case Report. ( 29651404 )
2018
24
Sphenoid wing dysplasia and plexiform neurofibroma in neurofibromatosis type 1. ( 27061833 )
2018
25
Arteriovenous Malformation Underlying a Plexiform Neurofibroma: An Unusual Presentation. ( 28405554 )
2017
26
Plexiform neurofibroma as a cause of carpal tunnel syndrome in a radial deficiency patient. ( 28554231 )
2017
27
Rare triad of periampullary carcinoid, duodenal gastrointestinal stromal tumor and plexiform neurofibroma at hepatic hilum in neurofibromatosis type 1: a case report. ( 28851321 )
2017
28
Multivacuolated mucin-filled cells: a unique cell characteristic of plexiform neurofibroma. A report of 11 cases. ( 27816720 )
2017
29
Plexiform Neurofibroma Involving the Lacrimal Gland. ( 28203199 )
2017
30
Plexiform Neurofibroma Overlying Giant Café-au-lait Macule. ( 28405569 )
2017
31
Multiple Plexiform Neurofibroma of the Hand Misdiagnosed as Ganglion Cyst. ( 28442864 )
2017
32
Plexiform neurofibroma causing an ossifying subperiosteal haematoma: a rare case in the tibia of an 11-year-old girl. ( 28623408 )
2017
33
An Exceptional Case of Intraparotid Plexiform Neurofibroma Originating from Autonomic Fibers of the Auriculotemporal Nerve. ( 28634493 )
2017
34
An unexpected manifestation of extensive plexiform neurofibroma. ( 28681789 )
2017
35
Successful treatment by negative-pressure wound therapy for ulcer located on diffuse plexiform neurofibroma. ( 28734012 )
2017
36
Giant scalp plexiform neurofibroma associated with NF-1. ( 28928977 )
2017
37
Plexiform Neurofibroma of Clitoris. ( 29142769 )
2017
38
BCRP expression in schwannoma, plexiform neurofibroma and MPNST. ( 29179472 )
2017
39
Giant congenital Becker's nevus overlying a plexiform neurofibroma: Merely a coincidence or more than it? ( 29210362 )
2017
40
Choroidal Ganglioneuroma and Orbital Plexiform Neurofibroma Presenting as Buphthalmos in an Infant With Neurofibromatosis Type 1. ( 25186217 )
2016
41
Multifactorial pathological hip subluxation in neurofibromatosis type-1 (NF1) due to intra-articular plexiform neurofibroma, lumbar radiculopathy and neurofibromatous polyneuropathy. ( 27932436 )
2016
42
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells. ( 26840085 )
2016
43
Misdiagnosis of plexiform neurofibroma as venous malformation in pediatric patients. ( 26868134 )
2016
44
Initial Exploration on Temporal Branch of Facial Nerve Function Preservation in Plexiform Neurofibroma Resection. ( 27526236 )
2016
45
Unusual location of a plexiform neurofibroma in the fallopian tube: A case report. ( 27641440 )
2016
46
Plexiform neurofibroma. ( 27824540 )
2016
47
Solitary Non Syndromic Oral Plexiform Neurofibroma: a Case Report and Review of Literature. ( 27840843 )
2016
48
Magnetic resonance neurographic confirmation of extensive Plexiform neurofibroma in neurofibromatosis-1 presenting as ambiguous genitalia. ( 27857458 )
2016
49
Congenital extra calvarial plexiform neurofibroma in occipito-cervical region with Occipital bone defect with neurofibromatosis type 1 and segmental neurofibromatosis: Case report and review of literature. ( 28217149 )
2016
50
Oral plexiform neurofibroma. ( 30895014 )
2016

Variations for Plexiform Neurofibroma

ClinVar genetic disease variations for Plexiform Neurofibroma:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 NF1 NM_000267.3(NF1): c.5750-1G> A single nucleotide variant Likely pathogenic rs1057518974 GRCh38 Chromosome 17, 31334837: 31334837
2 NF1 NM_000267.3(NF1): c.5750-1G> A single nucleotide variant Likely pathogenic rs1057518974 GRCh37 Chromosome 17, 29661855: 29661855

Copy number variations for Plexiform Neurofibroma from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 109397 17 25800000 31800000 Deletion NF1 Plexiform neurofibroma
2 109445 17 26082 26121 Microdeletion SUZ12 Plexiform neurofibroma
3 109456 17 26183 26246 Microdeletion ATAD5 Plexiform neurofibroma
4 109470 17 26273 26310 Microdeletion CENTA2 Plexiform neurofibroma
5 109475 17 26322 26351 Microdeletion RNF135 Plexiform neurofibroma
6 109535 17 26645 26648 Microdeletion OMG Plexiform neurofibroma
7 109543 17 26668 26672 Microdeletion EVI2A Plexiform neurofibroma
8 109598 17 27203 27210 Microdeletion C17orf79 Plexiform neurofibroma

Expression for Plexiform Neurofibroma

Search GEO for disease gene expression data for Plexiform Neurofibroma.

Pathways for Plexiform Neurofibroma

Pathways related to Plexiform Neurofibroma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.36 BUB1B NEK2

GO Terms for Plexiform Neurofibroma

Cellular components related to Plexiform Neurofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytosol GO:0005829 9.63 ANK3 BUB1B NEK2 NF1 NF2 SPRED1
2 chromosome, centromeric region GO:0000775 9.26 BUB1B NEK2
3 condensed chromosome kinetochore GO:0000777 8.96 BUB1B NEK2
4 cytoskeleton GO:0005856 8.92 ANK3 BUB1B NEK2 NF2

Biological processes related to Plexiform Neurofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of MAPK cascade GO:0043408 9.26 NF1 SPRED1
2 negative regulation of cell-matrix adhesion GO:0001953 9.16 NF1 NF2
3 negative regulation of protein kinase activity GO:0006469 9.13 NF1 NF2 SPRED1
4 negative regulation of MAPK cascade GO:0043409 8.8 NF1 NF2 SPRED1

Molecular functions related to Plexiform Neurofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoskeletal protein binding GO:0008092 8.62 ANK3 NF2

Sources for Plexiform Neurofibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....